Ss AL, Diaz-Griffero F: TNPO3 is required for HIV-1 replication afterSs AL, Diaz-Griffero F: TNPO3

Ss AL, Diaz-Griffero F: TNPO3 is required for HIV-1 replication after
Ss AL, Diaz-Griffero F: TNPO3 is required for HIV-1 replication after nuclear import but prior to integration and binds the HIV-1 core. J Virol 2012, 86:5931?936. 2. Logue EC, Taylor KT, Goff PH, Landau NR: The cargo-binding domain of transportin 3 is required for lentivirus nuclear import. J Virol 2011, 85:12950?1. 3. De Iaco A, Luban J: Inhibition of HIV-1 infection by TNPO3 depletion is determined by capsid and detectable after viral cDNA enters the nucleus. Retrovirology 2011, 8:98. 4. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, Lieberman J, Elledge SJ: Identification of host proteins PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/28878015 required for HIV infection through a functional genomic screen. Science 2008, 319:921?26. 5. Christ F, Thys W, De Rijck J, Gijsbers R, Albanese A, Arosio D, Emiliani S, Rain JC, Benarous R, Cereseto A, Debyser Z: Transportin-SR2 imports HIV into the nucleus. Curr Biol 2008, 18:1192?202. 6. Krishnan L, Matreyek KA, Oztop I, Lee K, Tipper CH, Li X, Dar MJ, Kewalramani VN, Engelman A: The requirement for cellular transportin 3 (TNPO3 or TRN-SR2) during infection maps to human immunodeficiency virus type 1 capsid and not integrase. J Virol 2010, 84:397?06. 7. Thys W, De Houwer S, Demeulemeester J, Taltynov O, Vancraenenbroeck R, Gerard M, De Rijck J, Gijsbers R, Christ F, Debyser Z: Interplay between HIV entry and transportin-SR2 dependency. Retrovirology 2011, 8:7. 8. Levin A, Hayouka Z, Friedler A, Loyter A: Transportin 3 and importin alpha are required for effective nuclear import of HIV-1 integrase in virusinfected cells. Nucleus 2010, 1:422?31. 9. Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, Castle JC, Stec E, Ferrer M, Strulovici B, Hazuda DJ, Espeseth AS: Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 2008, 4:495?04. 10. Konig R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, Irelan JT, Chiang CY, Tu BP, De Jesus PD, Lilley CE, et al: Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 2008, 135:49?0. 11. Shah VB, Shi J, Hout DR, Oztop I, Krishnan L, Ahn J, Shotwell MS, Engelman A, Aiken C: The host proteins transportin SR2/TNPO3 and cyclophilin a exert opposing effects on HIV-1 uncoating. J Virol 2013, 87:422?32. 12. Lee K, Ambrose Z, Martin TD, Oztop I, Mulky A, Julias JG, Vandegraaff N, Baumann JG, Wang R, Yuen W, et al: Flexible use of nuclear import pathways by HIV-1. Cell Host Microbe 2010, 7:221?33. 13. Zhou L, Sokolskaja E, Jolly C, James W, Cowley SA, Fassati A: Transportin 3 promotes a nuclear maturation step required for efficient HIV-1 integration. PLoS Pathog 2011, 7:e1002194. 14. Lee K, Mulky A, Yuen W, Martin TD, Meyerson NR, Choi L, Yu H, Sawyer SL, Kewalramani VN: HIV-1 capsid-targeting domain of cleavage and polyadenylation specificity factor 6. J Virol 2012, 86:3851?860. 15. Lienlaf M, Hayashi F, Di Nunzio F, Tochio N, Kigawa T, Yokoyama S, DiazGriffero F: Contribution of E3-ubiquitin ligase activity to HIV-1 restriction by TRIM5alpha(rh): structure of the RING domain of HIV-1 integrase inhibitor 2 site TRIM5alpha. J Virol 2011, 85:8725?737.16. Shi J, Zhou J, Shah VB, Aiken C, Whitby K: Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/26104484 capsid destabilization. J Virol 2011, 85:542?49. 17. Price AJ, Fletcher AJ, Schaller T, Elliott T, Lee K, KewalRamani VN, Chin JW, Towers GJ, James LC: CPSF6 defines a conserved capsid interface that modulates HIV-1 replication. PLoS Pathog 2012, 8:e1002896. 18. Kataoka N, Bachorik JL, Dreyfuss G: Tr.